Incidence and predictors of interstitial lung disease (ILD) in Thai patients with early systemic sclerosis: Inception cohort study

被引:38
作者
Wangkaew, Suparaporn [1 ]
Euathrongchit, Juntima [2 ]
Wattanawittawas, Pittaporn [1 ]
Kasitanon, Nuntana [1 ]
Louthrenoo, Worawit [1 ]
机构
[1] Chiang Mai Univ, Dept Internal Med, Div Rheumatol, Chiang Mai 50000, Thailand
[2] Chiang Mai Univ, Fac Med, Div Diagnost Radiol, Chiang Mai 50000, Thailand
关键词
HRCT; Incidence; Interstitial lung disease; Predictors; Systemic sclerosis; RESOLUTION COMPUTED-TOMOGRAPHY; IDIOPATHIC PULMONARY-FIBROSIS; CT; HYPERTENSION; SURVIVAL; CHEST;
D O I
10.3109/14397595.2015.1115455
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To determine and compare the prevalence of interstitial lung disease (ILD), the severity of high-resolution computed tomography (HRCT) score and incidence rate (IR) of ILD between the two subsets of early-SSc (systemic sclerosis) patients. We also determined the factors associated with ILD.Methods: We used an inception cohort of early-SSc patients seen between January 2010 and June 2014. All patients underwent HRCT at study entry and annually thereafter.Results: One hundred and thirteen patients (66 females and 89 diffuse cutaneous SSc [dcSSc]) with a meanSD age of 53.4 +/- 8.4 years and mean disease duration of 12.9 +/- 10.3 months at cohort entry were enrolled. At enrollment, patients with dcSSc had a higher prevalence of ILD (78.7% vs. 45.8%, p=0.002), and a higher total HRCT score (10.3 +/- 9.5 vs. 4.4 +/- 5.6, p=0.001) compared with limited cutaneous SSc (lcSSc). DcSSc patients had a higher IR of ILD than lcSSc patients (58.8 vs.17.3 per 100 person-years, p<0.001). Univariable analysis revealed that male gender, presence of anti-Scl 70 and absent anti-centromere antibody was significant predictors of ILD. In Cox-regression analysis, a positive anti-centromere [hazard ratio (HR) 0.09 95% confidence interval (95% CI 0.01-0.73)] was a protective factor.Conclusions: DcSSc patients had more severe HRCT scores and higher IR of ILD compared with lcSSc patients. Male gender, presence of anti-Scl 70, and absent anti-centromere antibody predicted the future development of ILD in early-SSc patients.
引用
收藏
页码:588 / 593
页数:6
相关论文
共 50 条
  • [41] Interstitial lung disease and systemic sclerosis
    Launay, D.
    REVUE DE MEDECINE INTERNE, 2016, 37 : A16 - A21
  • [42] Interstitial lung disease in systemic sclerosis
    Wells, Athol U.
    PRESSE MEDICALE, 2014, 43 (10): : E329 - E343
  • [43] COMPARISON OF THE EFFICACY AND SAFETY OF CYCLOPHOSPHAMIDE (SP) AND RITUXIMAB (RTM) IN PATIENTS WITH SYSTEMIC SCLEROSIS (SSC) WITH INTERSTITIAL LUNG DISEASE (ILD)
    Koneva, O.
    Ananieva, L.
    Garzanova, L.
    Desinova, O.
    Ovsyannikova, O.
    Starovoytova, M.
    CHEST, 2020, 157 (06) : 373A - 373A
  • [44] Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
    Bergamasco, Aurore
    Hartmann, Nadine
    Wallace, Laura
    Verpillat, Patrice
    CLINICAL EPIDEMIOLOGY, 2019, 11 : 257 - 273
  • [45] Incidence and prevalence of systemic sclerosis and systemic sclerosis with interstitial lung disease in the United States
    Fan, Yanni
    Bender, Shaun
    Shi, Weizhi
    Zoz, Donald
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (12) : 1539 - 1547
  • [46] Characteristics and risk factors of mortality in patients with systemic sclerosis-associated interstitial lung disease
    Jang, Hye Jin
    Woo, Ala
    Kim, Song Yee
    Yong, Seung Hyun
    Park, Youngmok
    Chung, Kyungsoo
    Lee, Su Hwan
    Leem, Ah Young
    Lee, Sang Hoon
    Kim, Eun Young
    Jung, Ji Ye
    Kang, Young Ae
    Kim, Young Sam
    Park, Moo Suk
    ANNALS OF MEDICINE, 2023, 55 (01) : 663 - 671
  • [47] Recent advances in the treatment of systemic sclerosis associated interstitial lung disease
    Kamenova, Antoniya
    Tzouvelekis, Argyris
    Margaritopoulos, George A.
    FRONTIERS IN MEDICINE, 2023, 10
  • [48] Impact of Systemic Sclerosis-Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival A Large Cohort Study of the German Network for Systemic Sclerosis
    Moinzadeh, Pia
    Bonella, Francesco
    Oberste, Max
    Weliwitage, Jithmi
    Blank, Nobert
    Riemekasten, Gabriela
    Mueller-Ladner, Ulf
    Henes, Joerg
    Siegert, Elise
    Guenther, Claudia
    Koetter, Ina
    Pfeiffer, Christiane
    Schmalzing, Marc
    Zeidler, Gabriele
    Korsten, Peter
    Susok, Laura
    Juche, Aaron
    Worm, Margitta
    Jandova, Ilona
    Ehrchen, Jan
    Sunderkoetter, Cord
    Keysser, Gernot
    Ramming, Andreas
    Schmeiser, Tim
    Kreuter, Alexander
    Lorenz, Hanns-Martin
    Hunzelmann, Nicolas
    Kreuter, Michael
    CHEST, 2024, 165 (01) : 132 - 145
  • [49] Rituximab treatment in patients with systemic sclerosis and interstitial lung disease
    Mohammed, Abdel Gaffar A.
    Alshihre, Ammar
    Al-Homood, Ibrahim Abdulrazag
    ANNALS OF THORACIC MEDICINE, 2017, 12 (04) : 294 - 297
  • [50] Interstitial Lung Disease in Systemic Sclerosis: Focus on Early Detection and Intervention
    Fischer, Aryeh
    Patel, Nina M.
    Volkmann, Elizabeth R.
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2019, 11 : 283 - 307